🇺🇸 FDA
Patent

US 9150926

Diagnosis and treatment of adrenocortical tumors using human microRNA-483

granted A61PA61P35/00

Quick answer

US patent 9150926 (Diagnosis and treatment of adrenocortical tumors using human microRNA-483) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P35/00